Camp4 Therapeutics Corp.宣布完成一轮超额认购的私募融资,融资规模高达1亿美元,所募资金将用于推进其针对Syngap1相关疾病的首创治疗方案的开发。
Camp4 Therapeutics Corp.宣布完成一轮超额认购的私募融资,融资规模高达1亿美元,所募资金将用于推进其针对Syngap1相关疾病的首创治疗方案的开发。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.